Search research articles
Contact Us
Filters
Showing results (21-30 of 106) with videos related to
Page
of 11
Sort By:
Journal of Medical Screening
|
January 8, 2010
The value of C-reactive protein in screening for future coronary heart disease events
David S Wald, Anuradhani Kasturiratne, Jonathan P Bestwick
Journal of Medical Screening
|
February 24, 2012
Adding ductus venosus blood flow as a categorical variable to the Combined and Integrated tests in Down's syndrome screening
Nicholas J Wald, Jonathan P Bestwick, Antoni Borrell
Prenatal Diagnosis
|
March 21, 2012
Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome
Jonathan P Bestwick, Wayne J Huttly, Nicholas J Wald
Prenatal Diagnosis
|
July 6, 2006
Sequential and contingent prenatal screening for Down syndrome
Nicholas J Wald, Alicja R Rudnicka, Jonathan P Bestwick
Prenatal Diagnosis
|
June 2, 2006
Cross-trimester marker ratios in prenatal screening for Down syndrome
Nicholas J Wald, Jonathan P Bestwick, Joan K Morris
F1000Research
|
November 24, 2017
Prenatal maternal plasma DNA screening for cystic fibrosis: A computer modelling study of screening performance
Robert W Old, Jonathan P Bestwick, Nicholas J Wald
Journal of Medical Screening
|
June 14, 2013
Detection of trisomy 18 and trisomy 13 using first and second trimester Down's syndrome screening markers
Jonathan P Bestwick, Wayne J Huttly, Nicholas J Wald
Expert Review of Molecular Diagnostics
|
February 7, 2022
The potential utility of smell testing to screen for neurodegenerative disorders
Gregory R Goodwin, Jonathan P Bestwick, Alastair J Noyce
European Thyroid Journal
|
May 1, 2014
Reply
John H Lazarus, Jonathan P Bestwick, Nicholas J Wald
Journal of Medical Screening
|
April 4, 2022
'Risk or chance': Authors' response
Nicholas J Wald, Jonathan P Bestwick, Joan K Morris
Page
of 11
Search research articles
Search
Showing results (21-30 of 106) with videos related to
Sort By:
Page
of 11
Journal of Medical Screening
|
January 8, 2010
The value of C-reactive protein in screening for future coronary heart disease events
David S Wald, Anuradhani Kasturiratne, Jonathan P Bestwick
Journal of Medical Screening
|
February 24, 2012
Adding ductus venosus blood flow as a categorical variable to the Combined and Integrated tests in Down's syndrome screening
Nicholas J Wald, Jonathan P Bestwick, Antoni Borrell
Prenatal Diagnosis
|
March 21, 2012
Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome
Jonathan P Bestwick, Wayne J Huttly, Nicholas J Wald
Prenatal Diagnosis
|
July 6, 2006
Sequential and contingent prenatal screening for Down syndrome
Nicholas J Wald, Alicja R Rudnicka, Jonathan P Bestwick
Prenatal Diagnosis
|
June 2, 2006
Cross-trimester marker ratios in prenatal screening for Down syndrome
Nicholas J Wald, Jonathan P Bestwick, Joan K Morris
F1000Research
|
November 24, 2017
Prenatal maternal plasma DNA screening for cystic fibrosis: A computer modelling study of screening performance
Robert W Old, Jonathan P Bestwick, Nicholas J Wald
Journal of Medical Screening
|
June 14, 2013
Detection of trisomy 18 and trisomy 13 using first and second trimester Down's syndrome screening markers
Jonathan P Bestwick, Wayne J Huttly, Nicholas J Wald
Expert Review of Molecular Diagnostics
|
February 7, 2022
The potential utility of smell testing to screen for neurodegenerative disorders
Gregory R Goodwin, Jonathan P Bestwick, Alastair J Noyce
European Thyroid Journal
|
May 1, 2014
Reply
John H Lazarus, Jonathan P Bestwick, Nicholas J Wald
Journal of Medical Screening
|
April 4, 2022
'Risk or chance': Authors' response
Nicholas J Wald, Jonathan P Bestwick, Joan K Morris
Page
of 11